Voting Now Open in the ASCO Election
ASCO encourages all eligible members to cast their ballots to choose new Society leaders. Eligible members are those who have been awarded and hold the degree of Doctor of Medicine, Doctor of Osteopathy, Doctor of Philosophy, Doctor of Pharmacy, Doctor of Medical Science, Doctor of Nursing Science, Doctor of Nursing Practice, or equivalent doctoral-level degree as determined by the Society and the Association, and who are in good standing as of October 17, 2022.
The voting period closes on Tuesday, December 6, 2022, at 3:00 PM Eastern Standard Time, USA. All ballots (online or paper) must be received by this time.
Election results will be announced mid-December 2022 and newly elected leaders will begin their terms in office in June 2023. Please contact ASCO Election with any questions.
View the COI disclosures for the ASCO election candidates, current as of October 27, 2022.
President-Elect Candidate (one seat, 4-year term)
Dr. Zon currently practices as Physician Emeritus at Michiana Hematology Oncology in Mishawaka, IN, where she served as Past-President. She formerly served as Medical Director of Oncology Research at Memorial Hospital and NCI CCOP Associate and then Principal Investigator until 2013 for the Northern Indiana Cancer Research Consortium, the only NCI designated Community Cancer Oncology Program in the state of Indiana. Dr. Zon is an active volunteer for ASCO, most recently being awarded ASCO’s Advocate of the Year for her significant advocacy work on behalf of individuals living with cancer and their cancer care teams and was the recipient of ASCO’s Distinguished Achievement Award. Dr. Zon is a Past Chair of ASCO’s Government Relations Committee, where she provided distinguished leadership in the society’s advocacy efforts. She also served on the Board of Directors from 2010 to 2013, along with participating in many other ASCO related responsibilities.
Board of Directors – Designated Community Oncologist Candidates (one seat, 4-year term)
Dr. Patt is the executive vice president of Texas Oncology PA and a clinical professor at Dell Medical School at The University of Texas at Austin. She serves as the past-president of the Texas Society of Clinical Oncology (an ASCO State Affiliate) and as editor-in-chief of JCO Clinical Cancer Informatics. Dr. Patt is a member of the ASCO Expert Panels on Systemic Therapy for Advanced HER2+ Breast Cancer and Brain Metastases and Telemedicine Standards, and past member of the Nominating Committee among other volunteer service. She was a 2013-2014 ASCO Leadership Development Program participant and a recipient of both a Young Investigator Award and a Merit Award from Conquer Cancer, the ASCO Foundation.
Dr. Spigel is the chief scientific officer at Sarah Cannon Research Institute. He is a member of the ASCO-ACCC Collaboration to Increase Participation of Racial & Ethnic Minority Populations in Cancer, past chair of the Annual Meeting Education Committee and past member of the Clinical Practice Guidelines Committee and Health Services Committee in addition to other volunteer appointments.
Board of Directors – Designated Surgical Oncologist Candidates (one seat, 4-year term)
Dr. Katz is a professor of surgical oncology and the department chair of the Department of Surgical Oncology at The University of Texas MD Anderson Cancer Center. He is a member of the Journal of Clinical Oncology Editorial Board and a past track leader for ASCO’s Annual Meeting Scientific Program Committee. Dr. Katz was a 2017-2018 Leadership Development Program participant and has also served on the Clinical Practice Guidelines Committee and as an Annual Meeting Education Committee track leader.
Dr. Moore is associate director of clinical research, professor of gynecologic oncology, and director of the Oklahoma TSET Phase 1 Program at the Stephenson Cancer Center at the University of Oklahoma. She is a member of ASCO’s Cancer Communications Committee, serves as a journal author and peer reviewer, and is a past member of the Annual Meeting Education Committee and Clinical Practice Committee.
Board of Directors – Undesignated Member Candidates (one seat, 4-year term)
Dr. Polite is a professor of medicine, deputy section chief, executive medical director for Cancer Accountable Care at the University of Chicago and was recently appointed chief physician for the University of Chicago Medicine’s new facility in Northwest Indiana. He briefly served on the ASCO Board of Directors from 2019 to 2020 and currently serves on ASCO’s PAC Advisory Council, State of Cancer Care in America (SOCCA) Publications Group, and Clinical Practice Committee. Dr. Polite is past chair of ASCO’s Health Disparities Committee, Clinical Practice Committee, and Health Policy Leadership Development Program Oversight Work Group and was a two-time chair of the Government Relations Committee. He is a past participant of the Leadership Development Program and received a Career Development Award in 2008 from Conquer Cancer, the ASCO Foundation.
Dr. Temel is a professor of medicine at Harvard Medical School, clinical director of Thoracic Oncology at the Massachusetts General Hospital, co-director of the Cancer Outcomes Research and Education Program at the Massachusetts General Hospital Cancer Center, and co-leader of the Dana Farber/Harvard Cancer Center Outcomes Research Program. She was the 2018 Walther Cancer Foundation Supportive Oncology Award recipient and the 2005 Conquer Cancer Career Development Award recipient. She is a past member of the Annual Meeting Education Committee and Supportive Care in Oncology Symposium Steering Committee.
Nominating Committee – Undesignated Member Candidates (two seats, each a 3-year term)
Dr. Goff is an associate professor of medicine and executive medical director for the Vanderbilt-Ingram Cancer Center (VICC) Patient Care Center. She is a member of the ASCO Advantage faculty and is a past member of ASCO’s Digital Education Course Development Committee, Annual Meeting Scientific Program Committee, Education Committee, and Professional Development Committee, among other volunteer appointments.
Dr. Pal is co-director of City of Hope's Kidney Cancer Program and is the head of the kidney and bladder cancer disease team at the institution. He is an associate editor for Cancer.Net, previously served as chair of ASCO’s Cancer Communications Committee, and was a 2016-2017 Leadership Development Program participant. He is also a past member of the COVID-19 Response Task Force and Annual Meeting Scientific Program Committee.
Dr. Traina is an associate attending in the Breast Medicine Service at Memorial Sloan Kettering Cancer Center, where she also serves as vice chair in the Department of Medicine and co-Chair of MSK Outpatient Operations. She is an associate professor at Weill Cornell Medical College and a special contributing faculty member at Gerstner Sloan Kettering Graduate School. She is a past chair of the ASCO Membership Advisory Committee and present co-Chair of the Breast Cancer Guideline Advisory Group, among additional past volunteer service. She was a 2016-2017 ASCO Leadership Development Program participant and is a recent member of the ASCO Road to Recovery Task Force, which published learnings from the COVID-19 experience to improve clinical research and cancer care during the pandemic. She has served on the Breast Cancer Scientific Committee for past ASCO Annual Meetings, mentored IDEA award recipients, contributes to ASCO-SEP educational content and is a supporter of Conquer Cancer, the ASCO Foundation.
Dr. Vapiwala is Professor and Vice Chair of Education in the Department of Radiation Oncology, and Dean of Admissions at the Perelman School of Medicine at University of Pennsylvania. She specializes in the management of patients with genitourinary (GU) cancers, serving as the department's first Chief of GU Oncology. Dr. Vapiwala is a proud graduate of ASCO’s Leadership Development Program, and holds positions in multiple national oncology societies and organizations, including as Track Leader on the ASCO Annual Meeting Scientific Program committee, Co-chair of the ECOG-ACRIN GU Early Modality committee, and Treasurer/Secretary on the American Society for Radiation Oncology (ASTRO)’s Board of Directors. She currently serves on the editorial board for ASCO Digital Education, as well as the Journal of Clinical Oncology and JAMA Oncology. Prior to her role as Dean of Admissions, she served as Assistant Dean of Student Affairs, and also sat on the Executive Committee of the Association of Directors of Radiation Oncology Programs.